Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate

Bipolar Disorders, Supplement

Volumn 9, Issue 1, 2007, Pages 136-144

  Senturk, Vesile ^a   Goker, Ceren ^a   Bilgic, Ayhan ^a   Olmez, Senay ^a   Tugcu, Handan ^a   Oncu, Bedriye ^a   Cem Atbasoglu, E ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Bipolar disorder; Cognitive functions; Euthymic; Lithium; Valproate; Verbal memory

Indexed keywords

LITHIUM; VALPROIC ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; HUMAN; MALE; MEMORY DISORDER; MONOTHERAPY; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; REMISSION; SEX RATIO; VERBAL MEMORY;

ADOLESCENT; ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; COGNITION DISORDERS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; INTELLIGENCE TESTS; LITHIUM CHLORIDE; MALE; MEMORY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PROBLEM SOLVING; VALPROIC ACID; VERBAL LEARNING;

EID: 34548656242     PISSN: 13992406     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2007.00481.x     Document Type: Article

References (45)

1. Martinez-Aran A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161: 262-270.
2. Bearden CE, Glahn DC, Monkul ES et al. Sources of declarative memory impairment in bipolar disorder: Mnemonic processes and clinical features. Psychiatry Res 2006; 40: 47-58.
3. El-Badri SM, Ashton CH, Moore PB, Marsh VR, Ferrier IN. Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord 2001; 3: 79-87.
4. Ferrier IN, Stanton BR, Kelly TP, Scott J. Neuropsychological function in euthymic patients with bipolar disorder. Br J Psychiatry 1999; 175: 246-251.
5. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: A systemic review of cross-sectional evidence. Bipolar Disord 2006; 8: 103-116.
6. Goswami U, Sharma AN, Khastigir U et al. Neuropsychological dysfunction, soft neurological signs, and social disability in euthymic bipolar subjects. Br J Psychiatry 2006; 188: 366-373.
7. Robinson LJ, Thompson JM, Gallagher P et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93: 105-115.
8. Frangou S, Donaldson S, Hadjulis M, Landau S, Goldstein LH, for the Maudsley Bipolar Disorder Project. Executive dysfunction in bipolar disorder I and its clinical correlates. Biol Psychiatry 2005; 1: 859-864.
9. Van Gorp WG, Altshuler L, Theberge DC, Witkins J, Dixon W. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. Arch Gen Psychiatry 1998; 55: 41-46.
10. Zubieta JK, Huguelet P, O'Neil RL, Giordani BJ. Cognitive function in euthymic bipolar I disorder. Psychiatry Res 2001; 102: 9-20.
11. Van Gorp WG, Altshuler L, Theberge DC, Mintz J. Declarative and procedural memory in bipolar disorder. Biol Psychiatry 1999; 46: 525-531.
12. Frangou S, Dakhil N, Landau S, Kumari V. Fronto-temporal function may distinguish bipolar disorder from schizophrenia. Bipolar Disord 2006; 8: 47-55.
13. Clark L, Iversen SD, Goodwin GM. Sustained attention deficit in bipolar disorder. Br J Psychiatry 2002; 180: 313-319.
14. Thompson JM, Gallagher P, Hughes JH et al. Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry 2005; 186: 32-40.
15. Krabbendam L, Honig A, Wiersma J et al. Cognitive dysfunctions and white matter lesions in patients with bipolar disorder in remission. Acta Psychiatr Scand 2000; 101: 274-280.
16. Goswami U, Gulrajani C, Moore PB et al. Neurocognitive decline in bipolar mood disorder: Role of mood stabilizers. J Psychopharmacol 2002; 16 (Suppl.): A45.
17. Donaldson S, Goldstein LH, Landau S, Raymont V, Frangou S. The Maudsley Bipolar Disorder Project: The effect of medication, family history, and duration of illness on IQ and memory in bipolar I disorder. J Clin Psychiatry 2003; 64: 86-93.
18. Ferrier IN, Chowdhury R, Thompson JM, Watson S, Young AH. Neurocognitive function in unaffected first-degree relatives of patients with bipolar disorder: A preliminary report. Bipolar Disord 2004; 6: 319-322.
19. Glahn DC, Barrett J, Bearden CE et al. Dissociable mechanisms for memory impairment in bipolar disorder and schizophrenia. Psychol Med 2006; 36: 1085-1095.
20. Dickerson F, Boronow JJ, Stallings C, Origoni AE, Cole SK, Yolken RH. Cognitive functioning in schizophrenia and bipolar disorder: Comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status. Psychiatry Res 2004; 129: 45-53.
21. King DJ. Psychomotor impairment and cognitive disturbances induced by neuroleptics. Acta Psychiatr Scand 1994; 380: 53-58.
22. Stein RA, Strickland TL. A review of the neuropsychological effects of commonly used prescription medications. Arch Clin Neuropsychol 1998; 13: 259-284.
23. Savitz J, Solms M, Ramesar R. Neuropsychological dysfunction in bipolar affective disorder: A critical opinion. Bipolar Disord 2005; 7: 216-235.
24. Honig A, Arts BM, Ponds RW, Riedel WJ. Lithium induced cognitive side effects in bipolar disorder: A qualitative analysis and implications for daily practise. Int Clin Psychopharmacol 1999; 14: 167-171.
25. Nemeroff CB. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry 2000; 61 (Suppl.): 19-25.
26. Engelsmann F, Ghadirian AM, Grof P. Lithium treatment and memory assessment: Methodology. Neuropsychobiology 1992; 26: 113-119.
27. Stip E, Dufresne J, Lussier I, Yatham L. A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: Mild and selective effects on learning. J Affect Disord 2000; 60: 147-157
28. Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: Implications for the development of novel therapeutics. Psychopharmacol Bull 2001; 35: 5-49.
29. Moore GJ, Bebchuk JM, Hasanat K et al. Lithium increases n-acetyl-aspartate in the human brain: In vivo evidence in support of bcl-2's neurotrophic effects ? Biol Psychiatry 2000; 48: 1-8.
30. Fukumoto T, Morinobu S, Okamoto Y, Kagaya A, Yamawaki S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology 2001; 158: 100-106.
31. Akdemir A, Turkcapar MH, Orsel SD, Demirergi N, Dag I, Ozbay MH. Reliability and validity of the Turkish version of the Hamilton Depression Rating Scale. Compr Psychiatry 2001; 42: 161-165.
32. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity, and sensibility. Br J Psychiatry 1978; 113: 429-435.
33. Karakas S. BILNOT bataryasi el kitabi Noropsikolojik testler için araştirma ve gelistirme çalişmalari (Handbook of BILNOT Battery). Ankara: Dizayn Ofset, 2004.
34. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. Washington, DC: APA, 1994.
35. Hafkenscheid A. Psychometric evaluation of a standardized and expanded Brief Psychiatric Rating Scale. Acta Psychiatr Scand 1991; 84: 294-300.
36. Beneke M, Rasmus W. Clinical global impressions (EDEU): Some critical comments. Pharmacopsychiatrica 1992; 25: 171-176.
37. Post B, Merkus MP, de Bie RM, de Haan RJ, Speelman JD. Unified Parkinson's disease rating scale motor examination: Are ratings of nurses, residents in neurology, and movement disorders specialists interchangeable ? Mov Disord 2005; 20: 1577-1584.
38. Heaton RK. Wisconsin Card Sorting Test Manual. Odessa, FL: Psychological Assessment Resources, 1981.
39. Wechsler D. Wechsler Memory Scale-Revised. New York, NY: The Psychological Corporation, 1987.
40. Atkinson L, Cyr JJ, Doxey NC, Vigna CM. Generalizability of WAIS-R factor structure within and between populations. J Clin Psychol 1989; 45: 124-129.
41. Russell AJ, Munro J, Jones PB, Hayward P, Hemley DR, Murray RM. The National Adult Reading Test as a measure of premorbid IQ in schizophrenia. Br J Clin Psychol 2000; 39: 297-305.
42. Bilder RM, Mukherjee S, Rieder RO, Pandurangi AK. Symptomatic and neuropsychological components of defect states. Schizophr Bull 1985; 11: 409-419.
43. Glahn DC, Bearden CE, Cakir S et al. Differential working memory impairment in bipolar disorder and schizophrenia: Effects of lifetime history of psychosis. Bipolar Disord 2006; 8: 117-123.
44. Kusumo KS, Vaughan M. Effects of lithium salts on memory. Br J Psychiatry 1977; 131: 435-457.
45. Bearden CE, Hoffman KM, Cannon TD. The neuropsychology and neuroanatomy of bipolar affective disorder: A critical review. Bipolar Disord 2001; 3: 106-150.